This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cotroneo, N.
Right arrow Articles by Silverman, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cotroneo, N.
Right arrow Articles by Silverman, J. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2008, p. 2223-2225, Vol. 52, No. 6
0066-4804/08/$08.00+0     doi:10.1128/AAC.01410-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureus{triangledown}

Nicole Cotroneo,1 Robert Harris,2 Nancy Perlmutter,3 Terry Beveridge,2,4,{dagger} and Jared A. Silverman1*

Cubist Pharmaceuticals, Inc., 65 Hayden Avenue, Lexington, Massachusetts 02421,1 University of Guelph, Guelph, Ontario, Canada N1G 2W1,2 Howard M. Shapiro, M.D., P.C., West Newton, Massachusetts,3 MicroTEM, Inc., Elora, Ontario, Canada N0B 1S04

Received 31 October 2007/ Returned for modification 28 December 2007/ Accepted 24 March 2008

The ability of daptomycin to produce bactericidal activity against Staphylococcus aureus while causing negligible cell lysis has been demonstrated using electron microscopy and the membrane integrity probes calcein and ToPro3. The formation of aberrant septa on the cell wall, suggestive of impairment of the cell division machinery, was also observed.


* Corresponding author. Mailing address: Cubist Pharmaceuticals, Inc., 65 Hayden Avenue, Lexington, MA 02421. Phone: (781) 860-8405. Fax: (781) 861-1154. E-mail: Jared.Silverman{at}Cubist.com

{triangledown} Published ahead of print on 31 March 2008.

{dagger} Deceased.


Antimicrobial Agents and Chemotherapy, June 2008, p. 2223-2225, Vol. 52, No. 6
0066-4804/08/$08.00+0     doi:10.1128/AAC.01410-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Hachmann, A.-B., Angert, E. R., Helmann, J. D. (2009). Genetic Analysis of Factors Affecting Susceptibility of Bacillus subtilis to Daptomycin. Antimicrob. Agents Chemother. 53: 1598-1609 [Abstract] [Full Text]  
  • Sarig, H., Rotem, S., Ziserman, L., Danino, D., Mor, A. (2008). Impact of Self-Assembly Properties on Antibacterial Activity of Short Acyl-Lysine Oligomers. Antimicrob. Agents Chemother. 52: 4308-4314 [Abstract] [Full Text]  
  • Hobbs, J. K., Miller, K., O'Neill, A. J., Chopra, I. (2008). Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus. J Antimicrob Chemother 62: 1003-1008 [Abstract] [Full Text]  
  • Hawkey, P. M. (2008). Pre-clinical experience with daptomycin. J Antimicrob Chemother 62: iii7-iii14 [Abstract] [Full Text]